406 related articles for article (PubMed ID: 26701107)
1. The role of urinary nerve growth factor for the diagnosis and assessment of the biofeedback success in children with dysfunctional voiding.
Ergin G; Kibar Y; Ebiloğlu T; Irkılata HC; Kopru B; Kaya E; Uyanık M; Tapan S; Dayanc MM
J Pediatr Urol; 2016 Apr; 12(2):118.e1-6. PubMed ID: 26701107
[TBL] [Abstract][Full Text] [Related]
2. Sacral nerve stimulation reduces elevated urinary nerve growth factor levels in women with symptomatic detrusor overactivity.
Shalom DF; Pillalamarri N; Xue X; Kohn N; Lind LR; Winkler HA; Metz CN
Am J Obstet Gynecol; 2014 Nov; 211(5):561.e1-5. PubMed ID: 25019486
[TBL] [Abstract][Full Text] [Related]
3. Urinary nerve growth factor levels could be a biomarker for overactive bladder symptom: a meta-analysis.
Qu HC; Yan S; Zhang XL; Zhu XW; Liu YL; Wang P
Genet Mol Res; 2014 Apr; 13(4):8609-19. PubMed ID: 24782215
[TBL] [Abstract][Full Text] [Related]
4. Can children with either overactive bladder or dysfunctional voiding transition from one into the other: Are both part of a single entity?
Glassberg KI; Van Batavia JP; Combs AJ
J Pediatr Urol; 2016 Aug; 12(4):217.e1-8. PubMed ID: 27448848
[TBL] [Abstract][Full Text] [Related]
5. Can urinary nerve growth factor and bladder wall thickness correlation in children have a potential role to predict the outcome of non-monosymptomatic nocturnal enuresis?
Telli O; Samancı C; Sarıcı H; Hascıcek AM; Kabar M; Eroglu M
J Pediatr Urol; 2015 Oct; 11(5):265.e1-5. PubMed ID: 26051999
[TBL] [Abstract][Full Text] [Related]
6. The effects of pelvic floor muscle therapy on symptoms, voiding, and pelvic floor muscle activity parameters in children with overactive bladder.
Pekbay Y; Ergin O; Topuz B; Sarikaya S; Acar ZZ; Irkilata HC; Dayanç M
Neurourol Urodyn; 2019 Jun; 38(5):1430-1442. PubMed ID: 31006136
[TBL] [Abstract][Full Text] [Related]
7. Urinary nerve growth factor level is correlated with the severity of neurological impairment in patients with cerebrovascular accident.
Liu HT; Liu AB; Chancellor MB; Kuo HC
BJU Int; 2009 Oct; 104(8):1158-62. PubMed ID: 19338537
[TBL] [Abstract][Full Text] [Related]
8. Biofeedback as a first-line treatment for overactive bladder syndrome refractory to standard urotherapy in children.
Ebiloglu T; Kaya E; Köprü B; Topuz B; Irkilata HC; Kibar Y
J Pediatr Urol; 2016 Oct; 12(5):290.e1-290.e7. PubMed ID: 27102986
[TBL] [Abstract][Full Text] [Related]
9. Multi-center randomized controlled trial of cognitive treatment, placebo, oxybutynin, bladder training, and pelvic floor training in children with functional urinary incontinence.
van Gool JD; de Jong TP; Winkler-Seinstra P; Tamminen-Möbius T; Lax H; Hirche H; Nijman RJ; Hjälmås K; Jodal U; Bachmann H; Hoebeke P; Walle JV; Misselwitz J; John U; Bael A;
Neurourol Urodyn; 2014 Jun; 33(5):482-7. PubMed ID: 23775924
[TBL] [Abstract][Full Text] [Related]
10. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention.
Liu HT; Kuo HC
Neurourol Urodyn; 2009; 28(1):78-81. PubMed ID: 19089891
[TBL] [Abstract][Full Text] [Related]
11. Urinary nerve growth factor in patients with detrusor overactivity.
Korzeniecka-Kozerska A; Wasilewska A
Ir J Med Sci; 2015 Dec; 184(4):737-43. PubMed ID: 24951086
[TBL] [Abstract][Full Text] [Related]
12. Comparison of biofeedback therapy in children with treatment-refractory dysfunctional voiding and overactive bladder.
Tugtepe H; Thomas DT; Ergun R; Abdullayev T; Kastarli C; Kaynak A; Dagli TE
Urology; 2015 Apr; 85(4):900-4. PubMed ID: 25669732
[TBL] [Abstract][Full Text] [Related]
13. Urinary Nerve Growth Factor Can Predict Therapeutic Efficacy in Children With Overactive Bladder.
Fukui S; Aoki K; Morizawa Y; Miyake M; Fujimoto K
Urology; 2017 May; 103():214-217. PubMed ID: 28161379
[TBL] [Abstract][Full Text] [Related]
14. Overactive bladder (OAB): A symptom in search of a disease - Its relationship to specific lower urinary tract symptoms and conditions.
Van Batavia JP; Combs AJ; Fast AM; Glassberg KI
J Pediatr Urol; 2017 Jun; 13(3):277.e1-277.e4. PubMed ID: 28527720
[TBL] [Abstract][Full Text] [Related]
15. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder.
Yokoyama T; Kumon H; Nagai A
Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444
[TBL] [Abstract][Full Text] [Related]
16. [NERVE GROWTH FACTOR IN THE URINE OF PATIENTS WITH IDIOPATHIC DETRUSOR OVERACTIVITY AND OVERACTIVE BLADDER WITHOUT DETRUSOR OVERACTIVITY].
Krivoborodov GG; Kolesanova EF; Tur EI; Efremov NS
Urologiia; 2015; (3):19-22. PubMed ID: 26390554
[TBL] [Abstract][Full Text] [Related]
17. NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome.
Kim SR; Moon YJ; Kim SK; Bai SW
Yonsei Med J; 2015 Jan; 56(1):204-11. PubMed ID: 25510766
[TBL] [Abstract][Full Text] [Related]
18. Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy.
Liu HT; Lin H; Kuo HC
Neurourol Urodyn; 2011 Nov; 30(8):1525-9. PubMed ID: 21826717
[TBL] [Abstract][Full Text] [Related]
19. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
Liu HT; Kuo HC
Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
[TBL] [Abstract][Full Text] [Related]
20. Urinary nerve growth factor in children with overactive bladder: a promising, noninvasive and objective biomarker.
Oktar T; Kocak T; Oner-Iyidogan Y; Erdem S; Seyithanoglu M; Ziylan O; Kocak H
J Pediatr Urol; 2013 Oct; 9(5):617-21. PubMed ID: 22789557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
